Applications of the Caco-2 model in the design and development of orally active drugs: elucidation of biochemical and physical barriers posed by the intestinal epithelium

https://doi.org/10.1016/S0169-409X(96)00427-9Get rights and content

Abstract

Oral administration is the most important and preferred route of administration for small molecular weight conventional drugs. The overall bioavailability of an orally administered drug depends on many factors, including the physicochemical properties of the drug as well as the morphological and biochemical state of the intestinal epithelium. Our understanding of the factors governing oral delivery of drug molecules is far from complete. As a result, the approaches to solve the problems related to oral drug delivery are often empirical in nature. The multifaceted nature of the problems associated with poor oral bioavailability of drug molecules requires a systematic and reductionist approach to understand the underlying factors affecting the bioavailability and absorption of these molecules. Thus, use of appropriate in vitro models is extremely useful in elucidating the role of various physical and biochemical barriers (such as metabolic enzymes, drug transporters, and the multidrug resistance (MDR) P-glycoprotein) to drug absorption. In this chapter, we have discussed the use of one such in vitro model, i.e. the Caco-2 cells, in elucidating the roles of the physical and biochemical barriers to drug absorption posed by the intestinal epithelium. By using specific examples, we have illustrated how this improved understanding about the barriers to drug absorption can be used for the design and development of drug candidates with enhanced oral absorption.

References (84)

  • W.H.M. Peters et al.

    Cytochromes P450 in the intestinal mucosa of man

    Biochem. Pharmacol.

    (1989)
  • P. Artursson et al.

    Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells

    Biochem. Biophys. Res. Commun.

    (1991)
  • P. Artursson et al.

    Epithelial transport of drugs in cell culture. II: effect of extracellular calcium concentration on the paracellular transport of drugs of different lipophilicities across monolayers of the intestinal epithelial (Caco-2) cells

    J. Pharm. Sci.

    (1990)
  • J. Karlsson et al.

    The mucus layer as a barrier to drug absorption in monolayers if human intestinal epithelial HT29-H goblet cells

    Int. J. Pharm.

    (1993)
  • P. Colthup et al.

    Determination of ondansetron in plasma and its pharmacokinetics in the young and elderly

    J. Pharm. Sci.

    (1991)
  • D. Thwaites et al.

    Transepithelial glycylsarcosine transport in intestinal Caco-2 cells mediated by expression of H+-coupled carriers at both apical and basal membranes

    J. Biol. Chem.

    (1993)
  • D. Thwaites et al.

    H+-coupled dipeptide (glycylsarcosine) transport across apical and basal borders of human intestinal Caco-2 cell monolayers display distinctive characteristics

    Biochim. Biophys. Acta

    (1993)
  • T. Okano et al.

    H+ Coupled uphill transport of aminocephalosporins via the dipeptide transport system in rabbit intestinal brush-border membranes

    J. Biol. Chem.

    (1986)
  • V. Ganapathy et al.

    Role of pH gradient and membrane potential in dipeptide transport in intestinal and renal brush-border membrane vesicles from the rabbit

    J. Biol. Chem.

    (1983)
  • R.L. Juliano et al.

    A surface glycoprotein modulating drug permeability Chinese hamster ovary cell mutants

    Biochim. Biophys. Acta

    (1976)
  • P.S. Burton et al.

    Evidence for a polarized efflux system for peptides in the apical membrane of Caco-2 cells

    Biochem. Biophys. Res. Commun.

    (1993)
  • P.F. Augustijns et al.

    Evidence for a polarized efflux system in Caco-2 cells capable of modulating cyclosporin A transport

    Biochem. Biophys. Res. Commun.

    (1993)
  • M.A. McMillan

    Clinical pharmacokinetics of cyclosporin

    Pharmacol. Ther.

    (1989)
  • W.H.M. Peters et al.

    Glutathione S-transferase, cytochrome P450, and uridine 5′-diphosphate-giucuronosyltranferase in human small intestine and liver

    Gastroenterology

    (1989)
  • P. Watkins

    The role of cytochromes P-450 in cyclosporine metabolism

    J. Am. Acad. Dermatol.

    (1990)
  • J.C. Kolars et al.

    First-pass metabolism of cyclosporin by the gut

    Lancet

    (1991)
  • C.A. Lee et al.

    CYP3A4 Expressed by insect cells infected with a recombinant Baculovirus containing both CYP3A4 and human NADPH-cytochrome P450 reductase is catalytically similar to human liver microsomal CYP3A4

    Arch. Biochem. Biophys.

    (1995)
  • T.Z. Csaky

    Intestinal absorption of xenobiotics

  • J.L. Madara et al.

    Functional morphology of the mucosa of the small intestine

  • M.J. Jackson

    Drug transport across gastrointestinal epithelia

  • K.M. Hillgren et al.

    In vitro systems for studying intestinal drug absorption

    Med. Res. Rev.

    (1995)
  • C. Cordon-Cardo et al.

    Expression of the multidrug resistance gene product (p-glycoprotein) in human normal and tumor tissues

    J. Histochem. Cytochem.

    (1990)
  • C.-P. Siegers

    In vivo biliary excretion and the isolated perfused liver preparation

  • M. Pinto et al.

    Enterocytelike differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture

    Biol. Cell

    (1983)
  • J. Hidalgo et al.

    Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability

    Gastroenterology

    (1989)
  • A. Hilgers et al.

    Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa

    Pharm. Res.

    (1990)
  • P. Artursson

    Cell culture as models for drug absorption across the intestinal mucosa

    Crit. Rev. Ther. Drug Carrier Syst.

    (1991)
  • J. Cogburn et al.

    A model of human small intestinal absorptive cells. 1. Transport barrier

    Pharm. Res.

    (1991)
  • A. Blais et al.

    Common characteristics for Na+-dependent sugar transport in Caco-2 cells and human fetal colon

    J. Membr. Biol.

    (1987)
  • M. Yoshioka et al.

    Expression of dipeptidyl aminopeptidase IV during enterocytic differentiation of human colon cancer (Caco-2) cells

    Int. J. Cancer

    (1991)
  • M. Hu et al.

    Mechanism of L-α-methyldopa transport through a monolayer of polarized human intestinal epithelial cells (Caco-2)

    Pharm. Res.

    (1990)
  • Cited by (166)

    • Drug and Gene Delivery Materials and Devices

      2017, Emerging Nanotechnologies for Diagnostics, Drug Delivery and Medical Devices
    View all citing articles on Scopus
    1

    Present address: Department of Drug Metabolism and Pharmacokinetics, Du Pont Merck Pharmaceutical Co., Newark. DE 19714, USA.

    View full text